Your browser doesn't support javascript.
loading
Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients.
Christen, Friederike; Hoyer, Kaja; Yoshida, Kenichi; Hou, Hsin-An; Waldhueter, Nils; Heuser, Michael; Hills, Robert K; Chan, Willy; Hablesreiter, Raphael; Blau, Olga; Ochi, Yotaro; Klement, Piroska; Chou, Wen-Chien; Blau, Igor-Wolfgang; Tang, Jih-Luh; Zemojtel, Tomasz; Shiraishi, Yuichi; Shiozawa, Yusuke; Thol, Felicitas; Ganser, Arnold; Löwenberg, Bob; Linch, David C; Bullinger, Lars; Valk, Peter J M; Tien, Hwei-Fang; Gale, Rosemary E; Ogawa, Seishi; Damm, Frederik.
Afiliação
  • Christen F; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Department of Hematology, Oncology, and Tumor Immunology, Berlin Institute of Health, Berlin, Germany.
  • Hoyer K; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Department of Hematology, Oncology, and Tumor Immunology, Berlin Institute of Health, Berlin, Germany.
  • Yoshida K; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Hou HA; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Waldhueter N; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Department of Hematology, Oncology, and Tumor Immunology, Berlin Institute of Health, Berlin, Germany.
  • Heuser M; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Hills RK; Centre for Trials Research, Cardiff University, Cardiff, United Kingdom.
  • Chan W; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Department of Hematology, Oncology, and Tumor Immunology, Berlin Institute of Health, Berlin, Germany.
  • Hablesreiter R; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Department of Hematology, Oncology, and Tumor Immunology, Berlin Institute of Health, Berlin, Germany.
  • Blau O; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Department of Hematology, Oncology, and Tumor Immunology, Berlin Institute of Health, Berlin, Germany.
  • Ochi Y; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Klement P; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Chou WC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Blau IW; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Department of Hematology, Oncology, and Tumor Immunology, Berlin Institute of Health, Berlin, Germany.
  • Tang JL; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Zemojtel T; Berlin Institute of Health Core Genomics Facility, Charité, University Medical Center, Berlin, Germany.
  • Shiraishi Y; Laboratory of Sequence Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Shiozawa Y; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Thol F; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Ganser A; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Löwenberg B; Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Linch DC; Department of Haematology, University College London Cancer Institute, London, United Kingdom; and.
  • Bullinger L; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Department of Hematology, Oncology, and Tumor Immunology, Berlin Institute of Health, Berlin, Germany.
  • Valk PJM; German Cancer Consortium and German Cancer Research Center, Heidelberg, Germany.
  • Tien HF; Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Gale RE; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Ogawa S; Department of Haematology, University College London Cancer Institute, London, United Kingdom; and.
  • Damm F; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Blood ; 133(10): 1140-1151, 2019 03 07.
Article em En | MEDLINE | ID: mdl-30610028
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Translocação Genética / Leucemia Mieloide Aguda / Evolução Clonal / Mutação Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Translocação Genética / Leucemia Mieloide Aguda / Evolução Clonal / Mutação Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Estados Unidos